ArticleEcancermedicalscience2021

Neoadjuvant chemotherapy with biosimilar trastuzumab in human epidermal growth factor receptor 2 overexpressed non-metastatic breast cancer: patterns of use and clinical outcomes in India.

Anjana Joel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.